Caffeic acid

Caffeic acid is a hydroxycinnamic acid phenolic compound that inhibits α-glucosidase enzymes and modulates glucose metabolism pathways. Clinical studies demonstrate its ability to reduce systolic blood pressure by 3.87 mmHg and decrease fasting glucose by 0.45 mmol/L.

Origin & History

Caffeic acid (3,4-dihydroxycinnamic acid) is a naturally occurring hydroxycinnamic acid found widely in coffee beans, fruits (apples, berries), vegetables (artichokes, potatoes), and herbs (thyme, sage). It is typically extracted from plant sources via ethanol or hot water extraction followed by purification, yielding yellow crystals that are slightly soluble in water.

Historical & Cultural Context

Caffeic acid-rich plants have been used for millennia in traditional medicine: Artemisia species in Traditional Chinese Medicine for fever and inflammation since ~200 BCE, and holy basil in Ayurveda for antioxidant effects since ~1500 BCE. European herbalism has employed coffee, artichoke, and thyme since the 16th century for digestion, liver health, and wound healing.

Health Benefits

• Reduces body fat and improves glucose tolerance (moderate evidence from RCT with n=30 obese adults)
• Lowers systolic blood pressure by ~3.87 mmHg (moderate evidence from meta-analysis of 14 RCTs, n=457)
• Decreases fasting glucose by ~0.45 mmol/L (moderate evidence from same meta-analysis)
• Provides potent antioxidant protection via ROS scavenging and metal chelation (preliminary evidence from in vitro studies)
• Reduces inflammation through NF-κB modulation and cytokine suppression (preliminary evidence from mechanistic studies)

How It Works

Caffeic acid inhibits α-glucosidase and α-amylase enzymes, reducing carbohydrate digestion and glucose absorption. It activates AMP-activated protein kinase (AMPK) pathways, enhancing glucose uptake in skeletal muscle. The compound also inhibits angiotensin-converting enzyme (ACE) activity and promotes nitric oxide synthesis, contributing to vasodilation and blood pressure reduction.

Scientific Research

Human clinical evidence for caffeic acid is limited, with most data from chlorogenic acid-rich coffee extracts. A 2010 RCT (PMID: 20730802) found 5 g/day chlorogenic acid-enriched coffee reduced body fat in 30 obese adults over 12 weeks. A 2017 meta-analysis (PMID: 28631011) of 14 RCTs (n=457) showed modest reductions in blood pressure and fasting glucose from 100-600 mg/day chlorogenic acid sources.

Clinical Summary

A meta-analysis of 14 randomized controlled trials (n=457) demonstrated caffeic acid's ability to reduce systolic blood pressure by 3.87 mmHg and decrease fasting glucose by 0.45 mmol/L. A separate RCT with 30 obese adults showed improvements in body fat reduction and glucose tolerance with moderate evidence quality. Most studies used doses ranging from 200-400mg daily for 8-12 weeks. Evidence strength is considered moderate due to limited sample sizes and study duration variability.

Nutritional Profile

Caffeic acid (3,4-dihydroxycinnamic acid) is a hydroxycinnamic acid polyphenol with molecular weight of 180.16 g/mol. It is not a macronutrient or micronutrient itself but a bioactive phytochemical compound. Typical dietary intake ranges from 50–200 mg/day in individuals consuming polyphenol-rich diets. Common dietary sources include coffee (approximately 50–150 mg per 200 mL cup, primarily as chlorogenic acid ester), wine (5–40 mg/L), sunflower seeds (~1–3 mg/g), thyme (~0.9 mg/g fresh weight), and various fruits and vegetables. In food, caffeic acid exists predominantly in esterified forms (e.g., chlorogenic acid = caffeic acid + quinic acid), which affects bioavailability. Free caffeic acid bioavailability is relatively high (~95% absorption in small intestine based on ileostomy studies); however, esterified forms require hydrolysis by gut esterases and colonic microbiota before absorption, reducing overall bioavailability to approximately 33–95% depending on the food matrix. Peak plasma concentration after 200 mg oral dose reaches approximately 0.5–1.5 µmol/L within 1–2 hours. It undergoes extensive phase II metabolism (methylation, glucuronidation, sulfation) in intestinal epithelium and liver, with dihydrocaffeic acid as a primary metabolite. No caloric contribution, fat, protein, or fiber content is attributed to caffeic acid as an isolated compound. Key bioactive properties include catechol ring-mediated ROS scavenging (ORAC value approximately 1,500 µmol TE/g) and ferric/cupric ion chelation activity.

Preparation & Dosage

Clinically studied doses: 100-500 mg/day oral caffeic acid equivalents (from 200-400 mg chlorogenic acid sources), divided 2-3 times daily. Topical formulations use 0.1-1% caffeic acid in creams. No standardized extracts are common; studies used coffee polyphenols with 5-30% caffeic acid content. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Chlorogenic acid, Ferulic acid, Rosmarinic acid, Piperine, Quercetin

Safety & Interactions

Caffeic acid is generally well-tolerated with minimal reported side effects at typical supplemental doses. It may enhance the hypoglycemic effects of diabetes medications, requiring blood glucose monitoring. The compound can potentiate antihypertensive drugs due to its ACE-inhibitory properties. Safety during pregnancy and lactation has not been established, and use should be avoided without medical supervision.